基本信息
views: 192
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
My laboratory has been interested in the pathogenesis of murine coronavirus infections for several years. Now, we also study three respiratory human coronavirus infections: SARS (Severe Acute Respiratory Syndrome)-coronavirus, Middle East Respiratory syndrome (MERS)-coronavirus, SARS-CoV-2 (COVID-19), human coronavirus-OC43, and human coronavirus-NL63.
Mice infected with mouse hepatitis virus develop a demyelinating disease with many similarities to the human disease, multiple sclerosis. Research in my laboratory is aimed at determining the immunological and viral factors involved in the demyelinating process. Previously, we determined the CD4 and CD8 T cell epitopes recognized in the central nervous system (CNS) of infected mice. We showed that in mice infected chronically with the virus, cytotoxic T cell escape mutants arise. These mutations completely abrogate recognition by CD8 T cells and thereby facilitate persistence.
We have developed reverse genetics system for introducing mutations into the murine coronavirus, SARS-CoV, SARS-CoV-2, and MERS-CoV genomes. We also study the anti-inflammatory components that are needed to diminish immunopathological disease, with specific focus on regulatory CD4 T cells and IL-10. The ultimate goal of our work is to understand the interplay of pro and anti-inflammatory factors that result in myelin and lung destruction.
SARS-CoV, SARS-CoV-2, and MERS-CoV cause the most significant diseases of any of the human coronaviruses. The diseases are especially severe in aged populations. We are using mice infected with murine adapted strains of SARS-CoV and SARS-CoV-2 to understand the basis of these severe diseases. We also study the coronavirus that causes the Middle East Respiratory Syndrome (MERS-CoV). We have developed mouse models for studying MERS and evaluate several MERS-CoV specific vaccines and therapies. We also study immune responses in patients who survived MERS, in collaboration with investigators from the Kingdom of Saudi Arabia and from China. We have developed several mouse models for COVID-19 We are studying anosima, commonly found in COVID-19 patients and survivors.
Mice infected with mouse hepatitis virus develop a demyelinating disease with many similarities to the human disease, multiple sclerosis. Research in my laboratory is aimed at determining the immunological and viral factors involved in the demyelinating process. Previously, we determined the CD4 and CD8 T cell epitopes recognized in the central nervous system (CNS) of infected mice. We showed that in mice infected chronically with the virus, cytotoxic T cell escape mutants arise. These mutations completely abrogate recognition by CD8 T cells and thereby facilitate persistence.
We have developed reverse genetics system for introducing mutations into the murine coronavirus, SARS-CoV, SARS-CoV-2, and MERS-CoV genomes. We also study the anti-inflammatory components that are needed to diminish immunopathological disease, with specific focus on regulatory CD4 T cells and IL-10. The ultimate goal of our work is to understand the interplay of pro and anti-inflammatory factors that result in myelin and lung destruction.
SARS-CoV, SARS-CoV-2, and MERS-CoV cause the most significant diseases of any of the human coronaviruses. The diseases are especially severe in aged populations. We are using mice infected with murine adapted strains of SARS-CoV and SARS-CoV-2 to understand the basis of these severe diseases. We also study the coronavirus that causes the Middle East Respiratory Syndrome (MERS-CoV). We have developed mouse models for studying MERS and evaluate several MERS-CoV specific vaccines and therapies. We also study immune responses in patients who survived MERS, in collaboration with investigators from the Kingdom of Saudi Arabia and from China. We have developed several mouse models for COVID-19 We are studying anosima, commonly found in COVID-19 patients and survivors.
Research Interests
Papers共 508 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Juan Shi,Jian Zheng,Xiujuan Zhang,Wanbo Tai, Ryan Compas, Jack Deno, Natalie Jachym,Abhishek K Verma,Gang Wang,Xiaoqing Guan,Abby E Odle,Yushun Wan,
JCI insightno. 5 (2024)
Journal of virologypp.e0058424-e0058424, (2024)
Abhishek Kumar Verma,Shea Lowery, Li-Chin Lin, Eazhisaivallabi Duraisami,Juan E Abrahante Lloréns, Qiang Qiu, Marco Hefti,C Ron Yu, Mark W Albers,Stanley Perlman
bioRxiv : the preprint server for biology (2024)
The Lancetno. 10438 (2024): 1729-1731
MBIOno. 2 (2024): e0287823-e0287823
Proceedings of the National Academy of Sciences of the United States of Americano. 15 (2024): e2317222121-e2317222121
Peter J Szachowicz,Christine Wohlford-Lenane, Cobey J Heinen, Shreya Ghimire, Biyun Xue, Timothy J Boly,Abhishek Verma, Leila MašinoviĆ, Jennifer R Bermick,Stanley Perlman,David K Meyerholz,Alejandro A Pezzulo,
bioRxiv : the preprint server for biology (2024)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn